Saluda Medical key facts
- Developer of closed-loop neuron modulation devices intended to treat chronic neuropathic pain.
- Saluda Medical’s last known valuation is $435.0M (Dec 2025).
- It has raised $822.9M across 4 recorded rounds; the latest was Early Stage VC ($30.0M) in Oct 2025.
- 3 institutional filers report fund marks on Saluda Medical across 46 filings.
- Saluda Medical has filed 2 Form Ds with the SEC since 2023, most recently Nov 2025 ($30.0M sold to 26 investors).
- Status: Publicly Held.
- ·Watch Saluda Medical: the Monday email on marks, rounds and moves
Saluda Medical funding rounds
4 roundsSaluda Medical valuation
Saluda Medical is now publicly traded; this page covers its private-market history, where its last recorded valuation was $435 million (Dec 2025). Secondary trades, fund marks and rounds below are the private-market record; the listed share price is not tracked here.
Recent activity
In the last 90 days, Saluda Medical's record added 1 institutional fund mark (latest period Jul 2026).
How much has Saluda Medical raised?
Saluda Medical has raised $823 million across 4 recorded rounds since 2022. The largest was a $30 million early-stage round in Oct 2025.
Saluda Medical has filed 2 Form Ds with the SEC since 2023, most recently in Nov 2025 ($30 million sold to 26 investors).
Institutional holders and vehicles
3 SEC-registered funds reported 46 fair-value marks on Saluda Medical between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
Comparable companies
Comparable therapeutic devices names by valuation on PrivateMarketView: SetPoint Medical ($480 million), LightForce ($400 million) and Soufflé Therapeutics ($345 million).
About Saluda Medical
Developer of closed-loop neuron modulation devices intended to treat chronic neuropathic pain. The company's products are used for the patient's neural fingerprint to monitor and adapt the dose of electrical stimulation automatically and tailor the therapy to meet each patient's needs in real-time, enabling patients with chronic back pain to get improved treatment comfortably.
- Industry
- Therapeutic Devices
- Sector
- Healthcare
- HQ
- Bloomington, MN, United States
- Founded
- 2011
- Employees
- 483
- Website
- saludamedical.com/
- Ownership
- Publicly Held
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Saluda Medical’s last known valuation, Dec 2025. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.
Institutional fund marks on Saluda Medical
3 filers · latest Jul 20263 SEC-registered funds reported 46 fair-value marks on Saluda Medical between Apr 2025 and Jul 2026. Filer-level marks and implied $/share are available to Pro members.
Membership and data by Private Market View